Literature DB >> 25726749

Ranibizumab in the treatment of choroidal neovascularization associated with morning glory syndrome.

Gilda Cennamo1, Claudia Rossi1, Nunzio Velotti1, Giuseppe de Crecchio1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25726749     DOI： 10.1111/aos.12687

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  1 in total

1.  Intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to morning glory syndrome in a child.

Authors:  Abdullah Özkaya; Ihsan Yilmaz; Zeynep Alkin; Yalcin Karakucuk; Ahmet Taylan Yazici
Journal:  Saudi J Ophthalmol       Date:  2016-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.